ClinicalTrials.Veeva

Menu

Effect of Caudal Nalbuphine on Postoperative Emergence Agitation in Pediatrics Undergoing Infra-umbilical Surgeries

A

Assiut University

Status and phase

Unknown
Phase 1

Conditions

Agitation, Emergence
Post Operative Pain

Treatments

Drug: Bupivacain
Drug: Nalbuphine

Study type

Interventional

Funder types

Other

Identifiers

NCT05245721
17101501

Details and patient eligibility

About

Effect of caudal nalbuphine on postoperative emergence agitation in pediatrics undergoing infra-umbilical surgeries and pain assessment

Enrollment

80 estimated patients

Sex

All

Ages

2 to 12 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Age 2_12 years
  • Both genders
  • ASA I_II
  • Children undergoing infra-umbilical surgeries

Exclusion criteria

  • Guardians refusal
  • congenital anomalies at the lower spine or meringues
  • Increased intracranial pressure
  • Skin infection at site of injection
  • Bleeding diathesis
  • Known allergy to any drugs used

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

80 participants in 2 patient groups

Nalbuphine
Active Comparator group
Treatment:
Drug: Bupivacain
Drug: Nalbuphine
Bupivacaine
Active Comparator group
Treatment:
Drug: Bupivacain

Trial contacts and locations

0

Loading...

Central trial contact

Rehab Adel Ebrahim; Mohamed Fathy Mostafa, Assistant professor

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems